Excelsior Biopharma Inc. (6496.TWO)
TWD 30.0
(0.0%)
TWD 30.0
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 771.56 Million | 671.76 Million | 1.33 Billion | 1.44 Billion | 1.54 Billion |
| Cost of Revenue | 464.63 Million | 384.58 Million | 1.04 Billion | 1.13 Billion | 1.18 Billion |
| Gross Profit | 306.93 Million | 287.17 Million | 293.35 Million | 310.1 Million | 353.58 Million |
| Operating Expenses | 388.05 Million | 320.13 Million | 297.64 Million | 269.26 Million | 266.8 Million |
| Selling, General and Administrative Expenses | 325.54 Million | 277.81 Million | 241.65 Million | 211.96 Million | 216.26 Million |
| Research and Development Expenses | 62.51 Million | 42.31 Million | 55.99 Million | 57.3 Million | 50.54 Million |
| Other Expenses | - | 3.47 Million | 2.87 Million | 5.51 Million | - |
| Cost and Expenses | 852.69 Million | 704.72 Million | 1.34 Billion | 1.4 Billion | 1.45 Billion |
| Operating Income | -81.12 Million | -25.31 Million | -1.01 Million | 46.78 Million | 86.77 Million |
| Interest Expense | 6.36 Million | 4.34 Million | 4.53 Million | 2.11 Million | 1.24 Million |
| Income Tax Expense | 9.06 Million | 7.76 Million | 5.62 Million | 9.99 Million | 20.8 Million |
| Earnings before Tax | -81.95 Million | -25.99 Million | -10.02 Million | 45.29 Million | 91.81 Million |
| Net Income | -91.01 Million | -33.75 Million | -15.64 Million | 35.3 Million | 71.01 Million |
| Earnings Per Share Basic | -1.94 | -0.72 | -0.34 | 0.76 | 1.52 |
| Earnings Per Share Diluted | -1.98 | -0.71 | -0.34 | 0.73 | 1.52 |
| Weighted Average Shares Outstanding | 46.9 Million | 46.66 Million | 46.51 Million | 46.66 Million | 46.71 Million |
| Weighted Average Shares Outstanding (Diluted) | 45.91 Million | 47.5 Million | 46.51 Million | 49.25 Million | 46.85 Million |
| Gross Margin | 0.40 | 0.43 | 0.22 | 0.21 | 0.23 |
| EBIT Margin | -0.04 | 0.00 | 0.02 | 0.05 | 0.07 |
| Profit Margin | -0.12 | -0.05 | -0.01 | 0.02 | 0.05 |
| EBITDA | -29.36 Million | 4.41 Million | 23.15 Million | 74.14 Million | 105.3 Million |
| Earnings Before Tax Margin | -0.11 | -0.04 | -0.00 | 0.03 | 0.06 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 212.87 Million | 190.11 Million | 209.16 Million | 771.56 Million | 186.52 Million | 187.88 Million |
| Cost of Revenue | 114.5 Million | 106.1 Million | 112.08 Million | 464.63 Million | 110.95 Million | 121.85 Million |
| Gross Profit | 98.37 Million | 84 Million | 97.08 Million | 306.93 Million | 75.57 Million | 66.03 Million |
| Operating Expenses | 115.7 Million | 113.64 Million | 91.05 Million | 387.08 Million | 106.65 Million | 100.57 Million |
| Selling, General and Administrative Expenses | 95.29 Million | 93.39 Million | 79.03 Million | - | 84.6 Million | 83.83 Million |
| Research and Development Expenses | 20.4 Million | 20.24 Million | 12.02 Million | - | 22.05 Million | 16.73 Million |
| Other Expenses | -906 Thousand | -2.25 Million | 2.81 Million | 301 Thousand | -1.57 Million | -621 Thousand |
| Cost and Expenses | 230.2 Million | 219.74 Million | 203.13 Million | 851.71 Million | 217.61 Million | 222.42 Million |
| Operating Income | -16.61 Million | -31.78 Million | 11.06 Million | -74.6 Million | -32.03 Million | -32.8 Million |
| Interest Expense | 2.15 Million | 1.7 Million | 1.7 Million | 6.36 Million | 2.52 Million | 1.07 Million |
| Income Tax Expense | 1.22 Million | 873 Thousand | 2.3 Million | 9.06 Million | 2.37 Million | 2.37 Million |
| Earnings before Tax | -19.72 Million | -32.8 Million | 8.54 Million | -81.95 Million | -34.8 Million | -33.8 Million |
| Net Income | -20.95 Million | -33.67 Million | 6.24 Million | -91.01 Million | -37.17 Million | -36.17 Million |
| Earnings Per Share Basic | -0.46 | -0.73 | 0.14 | - | -0.81 | -0.79 |
| Earnings Per Share Diluted | -0.46 | -0.73 | 0.13 | - | -0.81 | -0.79 |
| Weighted Average Shares Outstanding | 45.54 Million | 46.13 Million | 46.39 Million | 46.9 Million | 45.88 Million | 45.78 Million |
| Weighted Average Shares Outstanding (Diluted) | 45.54 Million | 46.13 Million | 46.83 Million | 47.79 Million | 45.88 Million | 45.78 Million |
| Gross Margin | 0.46 | 0.44 | 0.46 | 0.40 | 0.41 | 0.35 |
| EBIT Margin | 0.01 | -0.08 | 0.13 | - | -0.08 | -0.14 |
| Profit Margin | -0.10 | -0.18 | 0.03 | -0.12 | -0.20 | -0.19 |
| EBITDA | 1.52 Million | -14.71 Million | 27.82 Million | - | -15.08 Million | -26.39 Million |
| Earnings Before Tax Margin | -0.08 | -0.17 | 0.05 | -0.10 | -0.17 | -0.17 |
WJG
WRN
APAJF
ABB
6492
6719